Passer au contenu

/ Research



In a Phase One-Two clinical trial, the vast majority of patients with blood cancers are on the road to recovery, thanks to the UM171 molecule,...
On December 5-6, the Université de Montréal will bring together students and scholars from Montréal’s universities to discuss the essential role of...
Dr Christopher E. Rudd has discovered a new cell therapy approach that boosts the immune response of T lymphocytes to malignant tumours.
A new Canadian public health campaign is launched to promote the importance of getting a good night's rest.

All the news

Innovation Laboratory


All the activities